Vascular Solutions Launches Reprocessing Service for ClosureFAST Vein Catheters
Vascular Solutions Inc. offers a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST catheter, manufactured and marketed by VNUS Medical Technologies Inc. is widely used for performing endovenous therapy for the treatment of varicose veins. Vascular Solutions' reprocessing service is designed to help physicians reduce medical waste and lower their costs.
Vascular Solutions offers the reprocessing service under contract with Northeast Scientific Inc. (NES), an established third-party reprocessor of medical devices. NES received 510(k) clearance from the U.S. Food and Drug Administration (FDA) Nov. 30, 2011 for reprocessing the ClosureFAST catheter.
NES has granted Vascular Solutions the exclusive right through Dec. 31, 2016 to market the ClosureFAST reprocessing service to hospitals and clinics within the United States through Vascular Solutions' direct sales force. Vascular Solutions has already begun to take orders for the ClosureFAST reprocessing service and NES has begun to receive used ClosureFAST catheters from several of these customers for reprocessing.
Hospitals and clinics that subscribe to the service send their used ClosureFAST catheters directly to NES for reprocessing. Upon completion of reprocessing, customers receive those same catheters back, ready for a second use. NES's validated reprocessing system for the ClosureFAST catheters involves multiple stages, including decontamination, cleaning, drying, packaging, labeling, sterilization, and biological quarantine testing. As part of the process, each catheter is subjected to function testing and undergoes multiple inspections to ensure that quality standards are met.